May 30, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2019-D-0298-0018
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2019-D-0298: Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry.